The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
May 2013
Volume 9 Supplement R
Editorials
Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects
Kjeldsen S,
Os I,
Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA1
Charting new frontiers in interventional medicine
Fajadet J
May 21, 2013 | 10.4244/EIJV9SRA2
The burden of hypertension
Kintscher U
May 21, 2013 | 10.4244/EIJV9SRA3
Topic reviews
A global approach to hypertension
van den Meiracker A
May 21, 2013 | 10.4244/EIJV9SRA4
Ruling out secondary causes of hypertension
Ott C,
Schneider M,
Schmieder R
May 21, 2013 | 10.4244/EIJV9SRA5
Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy
Waeber B,
Feihl F
May 21, 2013 | 10.4244/EIJV9SRA6
Home and ambulatory blood pressure in resistant hypertension
Grassi G,
Facchetti R,
Seravalle G,
Cuspidi C,
Mancia G
May 21, 2013
Pathophysiology I: the kidney and the sympathetic nervous system
de Jager R,
Blankestijn P
May 21, 2013 | 10.4244/EIJV9SRA8
The “resistant hypertension team”: focus on a multidisciplinary approach to hypertension
Potthoff S,
Rump L,
Vonend O
May 21, 2013 | 10.4244/EIJV9SRA9
Response and non-response to renal denervation: who is the ideal candidate?
Ukena C,
Cremers B,
Ewen S,
Böhm M,
Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA10
Updated ESH position paper on interventional therapy of resistant hypertension
Schmieder R,
Redon J,
Grassi G,
Kjeldsen S,
Mancia G,
Narkiewicz K,
Parati G,
Ruilope L,
van de Borne P,
Tsioufis K
May 21, 2013 | 10.4244/EIJV9SRA11
Challenging anatomy, how to treat or not to treat?
Zeller T,
Rastan A,
Macharzina R,
Noory E
May 21, 2013 | 10.4244/EIJV9SRA12
Current technologies
Current technologies: an introduction
Daemen J
May 21, 2013 | 10.4244/EIJV9SRA13
Procedural considerations
Renal denervation: tips and tricks to perform a technically successful procedure
Bertog S,
Blessing E,
Vaskelyte L,
Hofmann I,
Id D,
Sievert H
May 21, 2013 | 10.4244/EIJV9SRA14
Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters
Ammar S,
Ladich E,
Steigerwald K,
Deisenhofer I,
Joner M
May 21, 2013 | 10.4244/EIJV9SRA15
Follow-up, study design and outcome parameters
Volpe M,
Battistini A,
Tocci G
May 21, 2013 | 10.4244/EIJV9SRA16
Expanding the indication spectrum
Renal denervation: expanding the indication
Daemen J,
Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA17
Obstructive sleep apnoea, resistant hypertension and renal denervation
Witkowski A,
Kądziela J
May 21, 2013 | 10.4244/EIJV9SRA18
Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias
Ukena C,
Mahfoud F,
Linz D,
Böhm M,
Neuberger H-R
May 21, 2013 | 10.4244/EIJV9SRA19
Expanding the indication spectrum: renal denervation in diabetes
Mahfoud F,
Ewen S,
Ukena C,
Linz D,
Sobotka P,
Cremers B,
Böhm M
May 21, 2013 | 10.4244/EIJV9SRA20
Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure
Böhm M,
Ewen S,
Linz D,
Reil J-C,
Schirmer S,
Ukena C,
Mahfoud F
May 21, 2013 | 10.4244/EIJV9SRA21
Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation
Hering D,
Esler M,
Schlaich M
May 21, 2013 | 10.4244/EIJV9SRA22
Efficacy of baroreflex activation therapy for the treatment of resistant hypertension
Briasoulis A,
Bakris G
May 21, 2013 | 10.4244/EIJV9SRA23
Restoring autonomic balance: future therapeutic targets
Sobotka P,
Osborn J,
Paton J
May 21, 2013 | 10.4244/EIJV9SRA24
Pulmonary arterial hypertension: pharmacologic therapies and potential pulmonary artery denervation treatment
Zhang Y-J,
Li M-H,
Chen S
May 21, 2013 | 10.4244/EIJV9SRA25
The crystal ball
Potential new indications and future studies
Sudano I,
Noll G,
Lüscher T
May 21, 2013 | 10.4244/EIJV9SRA26